An evaluation of hydrocortisone dosing for neonatal refractory hypotension

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objective: The objective of the study was to compare blood pressure, vasoactive medication requirements and adverse outcomes after administration of high- versus low-dose hydrocortisone (HC) in preterm infants. Study Design: This is a retrospective analysis of 106 infants ≤28 weeks gestational age with hypotension requiring vasoactive infusions and high-dose (4 mg kg-1 per day, n=50), low-dose (1 to 3 mg kg-1 per day, n=20) or no HC (n=36) from 2011 to 2015. Groups were compared by two-tailed t-test or χ2, and correlation estimated by multivariable logistic regression. Results: There were no differences in measured efficacy between the low- and high-dose groups. Infants with pre-treatment cortisol >15 mcg dl-1 who received HC therapy showed less improvement in vasoactive burden, increased hyperglycemia (P=0.015) and increased death independent of HC dose (odds ratio 26.3, 3.5 to 198.3, P=0.002). Conclusion: These results support using the lowest effective HC dose in preterm infants. In addition, HC therapy should likely be avoided in infants who are not cortisol deficient.

Original languageEnglish (US)
Pages (from-to)943-946
Number of pages4
JournalJournal of Perinatology
Volume37
Issue number8
DOIs
StatePublished - Aug 1 2017

Fingerprint

Hypotension
Hydrocortisone
Premature Infants
Hyperglycemia
Gestational Age
Therapeutics
Logistic Models
Odds Ratio
Blood Pressure

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

An evaluation of hydrocortisone dosing for neonatal refractory hypotension. / Peeples, E. S.

In: Journal of Perinatology, Vol. 37, No. 8, 01.08.2017, p. 943-946.

Research output: Contribution to journalArticle

@article{f8ced4f48cda4e85a18953c66eaf80bc,
title = "An evaluation of hydrocortisone dosing for neonatal refractory hypotension",
abstract = "Objective: The objective of the study was to compare blood pressure, vasoactive medication requirements and adverse outcomes after administration of high- versus low-dose hydrocortisone (HC) in preterm infants. Study Design: This is a retrospective analysis of 106 infants ≤28 weeks gestational age with hypotension requiring vasoactive infusions and high-dose (4 mg kg-1 per day, n=50), low-dose (1 to 3 mg kg-1 per day, n=20) or no HC (n=36) from 2011 to 2015. Groups were compared by two-tailed t-test or χ2, and correlation estimated by multivariable logistic regression. Results: There were no differences in measured efficacy between the low- and high-dose groups. Infants with pre-treatment cortisol >15 mcg dl-1 who received HC therapy showed less improvement in vasoactive burden, increased hyperglycemia (P=0.015) and increased death independent of HC dose (odds ratio 26.3, 3.5 to 198.3, P=0.002). Conclusion: These results support using the lowest effective HC dose in preterm infants. In addition, HC therapy should likely be avoided in infants who are not cortisol deficient.",
author = "Peeples, {E. S.}",
year = "2017",
month = "8",
day = "1",
doi = "10.1038/jp.2017.68",
language = "English (US)",
volume = "37",
pages = "943--946",
journal = "Journal of Perinatology",
issn = "0743-8346",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - An evaluation of hydrocortisone dosing for neonatal refractory hypotension

AU - Peeples, E. S.

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Objective: The objective of the study was to compare blood pressure, vasoactive medication requirements and adverse outcomes after administration of high- versus low-dose hydrocortisone (HC) in preterm infants. Study Design: This is a retrospective analysis of 106 infants ≤28 weeks gestational age with hypotension requiring vasoactive infusions and high-dose (4 mg kg-1 per day, n=50), low-dose (1 to 3 mg kg-1 per day, n=20) or no HC (n=36) from 2011 to 2015. Groups were compared by two-tailed t-test or χ2, and correlation estimated by multivariable logistic regression. Results: There were no differences in measured efficacy between the low- and high-dose groups. Infants with pre-treatment cortisol >15 mcg dl-1 who received HC therapy showed less improvement in vasoactive burden, increased hyperglycemia (P=0.015) and increased death independent of HC dose (odds ratio 26.3, 3.5 to 198.3, P=0.002). Conclusion: These results support using the lowest effective HC dose in preterm infants. In addition, HC therapy should likely be avoided in infants who are not cortisol deficient.

AB - Objective: The objective of the study was to compare blood pressure, vasoactive medication requirements and adverse outcomes after administration of high- versus low-dose hydrocortisone (HC) in preterm infants. Study Design: This is a retrospective analysis of 106 infants ≤28 weeks gestational age with hypotension requiring vasoactive infusions and high-dose (4 mg kg-1 per day, n=50), low-dose (1 to 3 mg kg-1 per day, n=20) or no HC (n=36) from 2011 to 2015. Groups were compared by two-tailed t-test or χ2, and correlation estimated by multivariable logistic regression. Results: There were no differences in measured efficacy between the low- and high-dose groups. Infants with pre-treatment cortisol >15 mcg dl-1 who received HC therapy showed less improvement in vasoactive burden, increased hyperglycemia (P=0.015) and increased death independent of HC dose (odds ratio 26.3, 3.5 to 198.3, P=0.002). Conclusion: These results support using the lowest effective HC dose in preterm infants. In addition, HC therapy should likely be avoided in infants who are not cortisol deficient.

UR - http://www.scopus.com/inward/record.url?scp=85019840468&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019840468&partnerID=8YFLogxK

U2 - 10.1038/jp.2017.68

DO - 10.1038/jp.2017.68

M3 - Article

C2 - 28518133

AN - SCOPUS:85019840468

VL - 37

SP - 943

EP - 946

JO - Journal of Perinatology

JF - Journal of Perinatology

SN - 0743-8346

IS - 8

ER -